FAQ > Glossary of Terms > F Series > Fill and Finish (Parenteral Drug)

A Series , B Series , C Series , D Series , E Series , F Series , G Series , H Series , I Series , K Series , L Series , M Series , N Series , O Series , P Series , Q Series , R Series , S Series , T Series , U Series , V Series , W Series , X Series , Y Series , Z Series

Face Velocity, Facility Flexibility, Facility User, Factor VIII(Hemophilia Factor), Factor IX(Hemophilia Factor), FDA Form 483, Fed Batch Fermentation, Federal Standard 209E, Feedback Loop, Feedwater, Fermentation, Fermenter, Fetal Calf Serum, Fever, Fibrin, Fibrinogen, Filtration, Fill and Finish(Parentral Drugs), Final Bulk Product, Finished Product, Firmware, FISH(Fluorescent In Situ Hybridization), Fissile Material, Flaggelae, Flammable Liquid, Flammable Solid, Flaws, Floc, Flocculation, Flow Cytometry, Flow Decay, Flow Restrictor, Fluid Service(Piping), Fluidized Bed, Fluorescein, Fluorinated Plastics, Flux Removers, Fomaldehyde, Forward Flow Test, Fouling, Fume Hoods, Functional Gene Tests, Functionality, Fungi, Fusion, Fusion Welding

Learn About Deadly Cancer Mesothelioma due to Asbestos Exposure, it can affect any one in the world

Fill and Finish (Parenteral Drugs)
Preparation of parenteral drugs, either LVPs or SVPs, demands the highest level of contamination control, because the human body's normal defenses against infection are bypassed when parenteral medications are introduced either intramuscularly (I.M.) or intravenously (I.V.) directly into the body. The processing of raw materials into finished dosage forms must comply at all times with cGMPs and must be able to support process validation. Mechanical design should include HVAC Classifications considered essential to attain global regulatory acceptance. For classifications, see the ISPE® Guide for Sterile Manufacturing Facilities. The desire for increased levels of sterility assurance has led the FDA to promote the use of terminal sterilization for aseptically filled products. The FDA has stated that terminal sterilization processing is the method of choice unless the manufacturer can show that it is detrimental to the product. Terminal sterilization may be accomplished using autoclaves that apply overpressure to balance the pressures that are developed across the inside and outside of the containers. Because of product sensitivities, biologics, and blood products are not appropriate applications for terminal sterilization